PYOTT DAVID E I 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Alnylam Director David Pyott Receives RSU and Option Award
What Happened
David E. I. Pyott, a director of Alnylam Pharmaceuticals (ALNY), received equity awards on May 20, 2026: 671 restricted stock units (RSUs) and 1,441 derivative shares (a grant tied to a stock option or similar award). Both grants show an acquisition price of $0 (typical for compensation grants); no cash proceeds or open‑market trades were reported.
Key Details
- Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (appears timely).
- Grants: 671 RSUs @ $0.00; 1,441 derivative shares @ $0.00.
- Shares owned after transaction: not specified in the provided summary.
- Footnotes of note:
- F1: The 671 RSUs represent contingent rights to one share each; they vest in full on the earlier of the first anniversary of grant or certain earlier retirement/resignation (if within 90 days prior to the first anniversary).
- F3: The derivative award (stock option/related instrument) vests in full on the earlier of the first anniversary of grant or certain earlier retirement/resignation (same 90‑day condition).
- F2: Separately, some ALNY common stock was purchased by the David E I Pyott Trust, of which Mr. Pyott is trustee (reported in the filing notes).
- Transaction code: A (award/grant) — not a purchase (P) or sale (S).
Context
- These entries are compensation awards rather than open‑market purchases or sales; awards are common for directors and reflect compensation, not an immediate market bet.
- The derivative award is subject to a vesting condition rather than an exercise/sale; no sale or cashless exercise was reported.
- For retail investors, awards signal company compensation activity but do not necessarily indicate the insider’s short‑term view on the stock.
Insider Transaction Report
Form 4
PYOTT DAVID E I
Director
Transactions
- Award
Common Stock
[F1]2026-05-20+671→ 1,582 total - Award
Stock Option (Right to Buy)
[F3]2026-05-20+1,441→ 1,441 totalExercise: $298.48From: 2027-05-20Exp: 2036-05-20→ Common Stock (1,441 underlying)
Holdings
- 27,900(indirect: By Trust)
Common Stock
[F2]
Footnotes (3)
- [F1]These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- [F2]The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
- [F3]The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Signature
Brett Budzinski, Attorney-in-Fact For: David E.I. Pyott|2026-05-22